EMBRIOPASS applicator — electronically controlled device for controlled transfer of embryos. (Q107897): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(‎Changed an Item: Fixing rounding issue)
(‎Removed claim: summary (P836): According to the WHO, between 60 and 80 million pairs of couples in the world are affected by fertility. 10-15 % of child-bearing age. in Poland, similarly. Estimates that 1,2-1,3 million pairs are missing, some of which require support for treatment by means of reproductive care. National experts estimate that ok.15. per year for pairs in PL require treatment by an in vitro method. The level of medicine in PL makes it possible to effect a ter...)
Property / summary
According to the WHO, between 60 and 80 million pairs of couples in the world are affected by fertility. 10-15 % of child-bearing age. in Poland, similarly. Estimates that 1,2-1,3 million pairs are missing, some of which require support for treatment by means of reproductive care. National experts estimate that ok.15. per year for pairs in PL require treatment by an in vitro method. The level of medicine in PL makes it possible to effect a terapnoea of about 50 centres assisted by non-fertility treatment centres, including the treatment of reproductive techniques. Article — The European IVF Monitoring (2011, SPIN-PTG)). A novum is the largest in terms of the number of patients treated and treated each year. One of the methods of treatment is the method of renewal of the method of treatment, which means that the transfer of the embryo to the woman’s uterus is made. This b.important and critical impact is determined by precision, manual capability, experimental and trained operators. The project is based on the fact that the project is based on the fact that the transfer of the embryo will increase the safety of the process and increase its efficiency. The development will be subject to: feeder, propulsion, control system with electron control parameters of the transfer and state of the battery and power supply. Target group. are people treating for infertility. The aim of the project is to: increase of the effectiveness of the embryo transfer to the woman’s uterus in the process of extracorporeal renewal in the treatment of non-foetuses., by the development and implementation of the EMBRC-ERIC prototype, are: 1/Uzysk. of the increase in the knowledge of the process of transferring the embryo to the woman’s uterus by means of projet. 200 case studies and trials and animal tests followed by clinical trials. 2/Przygot. and implementan.a prototype applicator for embryo transfer in the process of renewal process. (English)
 
Property / summary: According to the WHO, between 60 and 80 million pairs of couples in the world are affected by fertility. 10-15 % of child-bearing age. in Poland, similarly. Estimates that 1,2-1,3 million pairs are missing, some of which require support for treatment by means of reproductive care. National experts estimate that ok.15. per year for pairs in PL require treatment by an in vitro method. The level of medicine in PL makes it possible to effect a terapnoea of about 50 centres assisted by non-fertility treatment centres, including the treatment of reproductive techniques. Article — The European IVF Monitoring (2011, SPIN-PTG)). A novum is the largest in terms of the number of patients treated and treated each year. One of the methods of treatment is the method of renewal of the method of treatment, which means that the transfer of the embryo to the woman’s uterus is made. This b.important and critical impact is determined by precision, manual capability, experimental and trained operators. The project is based on the fact that the project is based on the fact that the transfer of the embryo will increase the safety of the process and increase its efficiency. The development will be subject to: feeder, propulsion, control system with electron control parameters of the transfer and state of the battery and power supply. Target group. are people treating for infertility. The aim of the project is to: increase of the effectiveness of the embryo transfer to the woman’s uterus in the process of extracorporeal renewal in the treatment of non-foetuses., by the development and implementation of the EMBRC-ERIC prototype, are: 1/Uzysk. of the increase in the knowledge of the process of transferring the embryo to the woman’s uterus by means of projet. 200 case studies and trials and animal tests followed by clinical trials. 2/Przygot. and implementan.a prototype applicator for embryo transfer in the process of renewal process. (English) / rank
Normal rank
 

Revision as of 17:15, 17 October 2020

Project in Poland financed by DG Regio
Language Label Description Also known as
English
EMBRIOPASS applicator — electronically controlled device for controlled transfer of embryos.
Project in Poland financed by DG Regio

    Statements

    country
    Poland
    0 references
    EU contribution
    585,208.09 zloty
    0 references
    140,449.94 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    budget
    1,069,851.56 zloty
    0 references
    256,764.37 Euro
    exchange rate to Euro
    0.24 Euro
    point in time
    13 January 2020
    0 references
    co-financing rate
    54.7 percent
    0 references
    start time
    7 June 2016
    0 references
    end time
    30 October 2018
    0 references
    beneficiary name (string)
    PRZYCHODNIA LEKARSKA "NOVUM" KATARZYNA KOZIOŁ, PIOTR LEWANDOWSKI SPÓŁKA JAWNA
    0 references
    beneficiary
    Q2523011
    0 references
    coordinate location

    52°14'1.3"N, 21°4'17.0"E
    0 references
    summary
    Wg WHO problem bezdzietności dotyczy 60–80 mln par na świecie. W krajach wys.rozwin. dot.10-15% par w wieku rozrodczym; w Polsce -podobnie. Szac.się, że problem niepłodn. ma 1,2–1,3 mln par, z czego część wymaga leczenia metodą wspomag. rozrodu. Krajowi eksperci szacują, że ok.15 tys.rocznie par w PL wymaga leczenia metodą in vitro. Poziom medycyny w PL pozwala na skut.terapię-mamy ok 50 ośrodków wspomaganej prokreacji zajmujących się leczeniem niepłodn. w tym terapią technikami rozrodu wspomag. ART. Zg. z ostatnim europ.rap.skuteczności EIM (European IVF Monitoring) (2011,SPiN-PTG))-Przych. Novum jest największa pod wzgl.liczby przyjmow. i leczonych pacjentów rocznie. Jedną z najefekt. metod terapii jest zapłodn.pozaustroj. którego finalnym etap.jest transfer zarodka do macicy kobiety. Ten b.ważny i mający krytyczny wpływ na skuteczn.zabieg jest b.zależny od precyzji, zdolności manual., doświadcz. i wyszkol.operatora. Projekt opiera się na założ. że elektronicznie sterow.urządz.do transferu zarodka zwiększy bezpiecz.zabiegu i podniesie jego efektywn., tj.skuteczność zapłodn.pozaustrojowego Zakres projektu obejmuje zaprojekt., wykonanie i przetest. na zwierzętach a następnie w badaniach klinicznych z udz.pacjentek Novum, prototypu aplikatora EMBRIOPASS. Opracowaniu będą podlegały: podajnik, napęd, układ sterujący z elektron.kontrolą parametrów transferu i nadzorem stanu baterii oraz układ zasilania. Grupą docel. są osoby leczące się na niepłodność. Celem gł. projektu jest: wzrost skuteczności zabiegu transferu zarodków do macicy kobiety w procesie zapłodn. pozaustrojowego w leczeniu niepłodn., poprzez oprac. i wdrożenie prototypu Aplikatora EMBRIOPASS Celami szczegół. projektu są: 1/ Uzysk. wzrostu wiedzy o procesie transferu zarodka do macicy kobiety poprzez przeprow. 200 studium przypadków i analizy procesu oraz testów na zwierzętach a następ. badań klinicznych. 2/ Przygot. i wykonan.prototypu APLIKATORA do transferu zarodków w procesie zapłodn. pozaustroj (Polish)
    0 references

    Identifiers

    Polish Kohesio ID
    RPMA.01.02.00-14-5674/16
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q107897&oldid=6432611"